Covered recipient · General Payments record
SHEELA LOHIYA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$13,157.59
- Reported across 391 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,022.60 | 92 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $284.89 | 11 |
| Novo Nordisk AS | $271.64 | 17 |
| Amgen Inc. | $176.09 | 8 |
| Medtronic, Inc. | $159.45 | 8 |
| SANOFI-AVENTIS U.S. LLC | $130.78 | 4 |
| Xeris Pharmaceuticals, Inc. | $111.24 | 5 |
| Radius Health, Inc. | $107.02 | 4 |
| Insulet Corporation | $93.96 | 3 |
| BETA BIONICS, INC. | $66.26 | 1 |
| Amneal Pharmaceuticals LLC | $66.00 | 4 |
| DEXCOM, INC. | $63.46 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $56.75 | 3 |
| ABBVIE INC. | $50.06 | 3 |
| Embecta Corp. | $45.68 | 2 |
| Corcept Therapeutics | $41.23 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40.33 | 2 |
| Tandem Diabetes Care, Inc. | $39.88 | 1 |
| Alexion Pharmaceuticals, Inc. | $34.86 | 2 |
| TheracosBio, LLC | $25.14 | 1 |
| Sandoz Inc. | $25.09 | 1 |
| Ultragenyx Pharmaceutical Inc. | $24.16 | 1 |
| MannKind Corporation | $23.32 | 1 |
| Echosens North America, Inc. | $22.06 | 1 |
| PFIZER INC. | $17.41 | 1 |
| Ascendis Pharma Inc | $16.83 | 1 |
| IBSA Pharma Inc. | $14.87 | 1 |
| Averitas Pharma Inc. | $14.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (92)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.